Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$66.81
0.240.36%
At close: -
$66.82
0.010000.01%
After Hours: 7:42 PM EDT
Comments
Loading...
CVS Health Analyst Ratings and Price Targets | NYSE:CVS | Benzinga
CVS Health Corp has a consensus price target of $80.08 based on the ratings of 26 analysts. The high is $100 issued by Morgan Stanley on November 2, 2023. The low is $62 issued by Cantor Fitzgerald on October 1, 2024. The 3 most-recent analyst ratings were released by Barclays, Truist Securities, and Wells Fargo on June 2, 2025, May 12, 2025, and May 6, 2025, respectively. With an average price target of $82.33 between Barclays, Truist Securities, and Wells Fargo, there's an implied 23.22% upside for CVS Health Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Truist Securities
Wells Fargo
RBC Capital
UBS
1calculated from analyst ratings
Analyst Ratings for CVS Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/02/2025 | Buy Now | 18.23% | Barclays | Andrew Mok56% | $82 → $79 | Maintains | Overweight | Get Alert |
| 05/12/2025 | Buy Now | 25.71% | Truist Securities | David Macdonald65% | $82 → $84 | Maintains | Buy | Get Alert |
| 05/06/2025 | Buy Now | 25.71% | Wells Fargo | Stephen Baxter54% | $76 → $84 | Maintains | Overweight | Get Alert |
| 05/05/2025 | Buy Now | 21.22% | RBC Capital | Ben Hendrix59% | $74 → $81 | Maintains | Outperform | Get Alert |
| 05/02/2025 | Buy Now | 6.26% | UBS | Kevin Caliendo71% | $67 → $71 | Maintains | Neutral | Get Alert |
| 05/02/2025 | Buy Now | 22.72% | Barclays | Andrew Mok56% | $73 → $82 | Maintains | Overweight | Get Alert |
| 04/15/2025 | Buy Now | 6.26% | Baird | Michael Ha38% | $51 → $71 | Maintains | Neutral | Get Alert |
| 04/11/2025 | Buy Now | 22.72% | Truist Securities | David Macdonald65% | $76 → $82 | Maintains | Buy | Get Alert |
| 04/09/2025 | Buy Now | 13.74% | Mizuho | Ann Hynes86% | $70 → $76 | Maintains | Outperform | Get Alert |
| 03/21/2025 | Buy Now | 10.75% | Piper Sandler | Jessica Tassan39% | $72 → $74 | Maintains | Overweight | Get Alert |
| 02/18/2025 | Buy Now | 21.22% | JP Morgan | Lisa Gill56% | $80 → $81 | Maintains | Overweight | Get Alert |
| 02/13/2025 | Buy Now | 9.25% | Wells Fargo | Stephen Baxter54% | $68 → $73 | Maintains | Overweight | Get Alert |
| 02/13/2025 | Buy Now | 13.74% | Truist Securities | David Macdonald65% | $60 → $76 | Maintains | Buy | Get Alert |
| 02/13/2025 | Buy Now | 9.25% | Barclays | Andrew Mok56% | $71 → $73 | Maintains | Overweight | Get Alert |
| 02/13/2025 | Buy Now | 12.24% | Leerink Partners | Michael Cherny78% | $55 → $75 | Upgrade | Market Perform → Outperform | Get Alert |
| 01/27/2025 | Buy Now | -2.72% | Evercore ISI Group | Elizabeth Anderson47% | $60 → $65 | Maintains | Outperform | Get Alert |
| 01/06/2025 | Buy Now | -10.21% | Truist Securities | David Macdonald65% | $67 → $60 | Maintains | Buy | Get Alert |
| 12/03/2024 | Buy Now | -1.23% | Deutsche Bank | George Hill60% | $66 → $66 | Upgrade | Hold → Buy | Get Alert |
| 11/25/2024 | Buy Now | 19.72% | TD Cowen | Charles Ryhee50% | $73 → $80 | Maintains | Buy | Get Alert |
| 11/25/2024 | Buy Now | -4.22% | Piper Sandler | Jessica Tassan39% | $72 → $64 | Maintains | Overweight | Get Alert |
| 11/20/2024 | Buy Now | 0.27% | Truist Securities | David Macdonald65% | $76 → $67 | Reiterates | Buy → Buy | Get Alert |
| 11/18/2024 | Buy Now | -1.23% | Wells Fargo | Stephen Baxter54% | $60 → $66 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/15/2024 | Buy Now | -13.2% | RBC Capital | Ben Hendrix59% | $68 → $58 | Maintains | Outperform | Get Alert |
| 11/07/2024 | Buy Now | -7.21% | UBS | Kevin Caliendo71% | $60 → $62 | Maintains | Neutral | Get Alert |
| 11/07/2024 | Buy Now | 6.26% | Barclays | Andrew Mok56% | $75 → $71 | Maintains | Overweight | Get Alert |
| 11/04/2024 | Buy Now | -10.21% | Wells Fargo | Stephen Baxter54% | $61 → $60 | Maintains | Equal-Weight | Get Alert |
| 10/24/2024 | Buy Now | -1.23% | Mizuho | Ann Hynes86% | $73 → $66 | Maintains | Outperform | Get Alert |
| 10/23/2024 | Buy Now | 12.24% | Barclays | Andrew Mok56% | $82 → $75 | Maintains | Overweight | Get Alert |
| 10/11/2024 | Buy Now | 13.74% | Truist Securities | David Macdonald65% | $66 → $76 | Maintains | Buy | Get Alert |
| 10/10/2024 | Buy Now | 22.72% | Barclays | Andrew Mok56% | $63 → $82 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/08/2024 | Buy Now | 12.24% | Evercore ISI Group | Elizabeth Anderson47% | $62 → $75 | Maintains | Outperform | Get Alert |
| 10/04/2024 | Buy Now | 27.21% | TD Cowen | Charles Ryhee50% | $59 → $85 | Upgrade | Hold → Buy | Get Alert |
| 10/01/2024 | Buy Now | -7.21% | Cantor Fitzgerald | Sarah James51% | $62 → $62 | Reiterates | Neutral → Neutral | Get Alert |
| 09/16/2024 | Buy Now | -7.21% | Cantor Fitzgerald | Sarah James51% | $62 → $62 | Reiterates | Neutral → Neutral | Get Alert |
| 09/10/2024 | Buy Now | -7.21% | Cantor Fitzgerald | Sarah James51% | $62 → $62 | Reiterates | Neutral → Neutral | Get Alert |
| 09/04/2024 | Buy Now | 1.77% | RBC Capital | Ben Hendrix59% | $68 → $68 | Reiterates | Outperform → Outperform | Get Alert |
| 08/19/2024 | Buy Now | -7.21% | Cantor Fitzgerald | Sarah James51% | $62 → $62 | Reiterates | Neutral → Neutral | Get Alert |
| 08/12/2024 | Buy Now | -8.71% | Wells Fargo | Stephen Baxter54% | $60 → $61 | Maintains | Equal-Weight | Get Alert |
| 08/09/2024 | Buy Now | -5.72% | Deutsche Bank | George Hill60% | $64 → $63 | Maintains | Hold | Get Alert |
| 08/08/2024 | Buy Now | -5.72% | Barclays | Andrew Mok56% | $65 → $63 | Maintains | Equal-Weight | Get Alert |
| 08/08/2024 | Buy Now | -7.21% | Cantor Fitzgerald | Sarah James51% | $58 → $62 | Maintains | Neutral | Get Alert |
| 08/08/2024 | Buy Now | -7.21% | Evercore ISI Group | Elizabeth Anderson47% | $65 → $62 | Maintains | Outperform | Get Alert |
| 07/23/2024 | Buy Now | -13.2% | Cantor Fitzgerald | Sarah James51% | $58 → $58 | Reiterates | Neutral → Neutral | Get Alert |
| 06/12/2024 | Buy Now | -13.2% | Cantor Fitzgerald | Sarah James51% | $58 → $58 | Reiterates | Neutral → Neutral | Get Alert |
| 05/30/2024 | Buy Now | 28.7% | JP Morgan | Lisa Gill56% | $101 → $86 | Maintains | Overweight | Get Alert |
| 05/30/2024 | Buy Now | -8.71% | Baird | Michael Ha38% | → $61 | Initiates | → Neutral | Get Alert |
| 05/08/2024 | Buy Now | 19.72% | Argus Research | Chris Graja66% | $100 → $80 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | -10.21% | Wells Fargo | Stephen Baxter54% | $76 → $60 | Maintains | Equal-Weight | Get Alert |
| 05/07/2024 | Buy Now | -11.7% | TD Cowen | Charles Ryhee50% | $99 → $59 | Downgrade | Buy → Hold | Get Alert |
| 05/02/2024 | Buy Now | 15.23% | B of A Securities | Michael Cherny78% | $95 → $77 | Maintains | Buy | Get Alert |
| 05/02/2024 | Buy Now | 10.75% | Goldman Sachs | Nathan Rice56% | $85 → $74 | Maintains | Buy | Get Alert |
| 05/02/2024 | Buy Now | -5.72% | Barclays | Andrew Mok56% | $78 → $63 | Maintains | Equal-Weight | Get Alert |
| 05/02/2024 | Buy Now | -10.21% | UBS | Kevin Caliendo71% | $85 → $60 | Downgrade | Buy → Neutral | Get Alert |
| 05/02/2024 | Buy Now | -1.23% | Truist Securities | David Macdonald65% | $90 → $66 | Reiterates | Buy → Buy | Get Alert |
| 05/02/2024 | Buy Now | 7.75% | Mizuho | Ann Hynes86% | $86 → $72 | Maintains | Buy | Get Alert |
| 05/01/2024 | Buy Now | -10.21% | Leerink Partners | Michael Cherny78% | → $60 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/01/2024 | Buy Now | -13.2% | Cantor Fitzgerald | Sarah James51% | $87 → $58 | Downgrade | Overweight → Neutral | Get Alert |
| 04/10/2024 | Buy Now | 30.2% | Cantor Fitzgerald | Sarah James51% | $87 → $87 | Reiterates | Overweight → Overweight | Get Alert |
| 04/08/2024 | Buy Now | 13.74% | Wells Fargo | Stephen Baxter54% | $83 → $76 | Maintains | Equal-Weight | Get Alert |
| 04/04/2024 | Buy Now | 30.2% | Cantor Fitzgerald | Sarah James51% | $87 → $87 | Reiterates | Overweight → Overweight | Get Alert |
| 03/15/2024 | Buy Now | 40.68% | Piper Sandler | Jessica Tassan39% | $93 → $94 | Maintains | Overweight | Get Alert |
| 03/06/2024 | Buy Now | 16.73% | Barclays | Andrew Mok56% | → $78 | Initiates | → Equal-Weight | Get Alert |
| 02/26/2024 | Buy Now | 31.7% | Leerink Partners | Michael Cherny78% | → $88 | Initiates | → Outperform | Get Alert |
| 02/08/2024 | Buy Now | 30.2% | Cantor Fitzgerald | Sarah James51% | $87 → $87 | Reiterates | Overweight → Overweight | Get Alert |
| 02/08/2024 | Buy Now | 25.71% | RBC Capital | Ben Hendrix59% | $86 → $84 | Maintains | Outperform | Get Alert |
| 12/22/2023 | Buy Now | 40.68% | HSBC | Daniela Bretthauer53% | → $94 | Initiates | → Buy | Get Alert |
| 12/11/2023 | Buy Now | 48.16% | TD Cowen | Charles Ryhee50% | $102 → $99 | Maintains | Outperform | Get Alert |
| 11/21/2023 | Buy Now | 30.2% | Cantor Fitzgerald | Sarah James51% | → $87 | Reiterates | Overweight → Overweight | Get Alert |
| 11/02/2023 | Buy Now | 28.7% | Mizuho | Ann Hynes86% | $88 → $86 | Maintains | Buy | Get Alert |
| 11/02/2023 | Buy Now | 28.7% | RBC Capital | Ben Hendrix59% | $91 → $86 | Maintains | Outperform | Get Alert |
| 11/02/2023 | Buy Now | 49.66% | Morgan Stanley | Erin Wright75% | $110 → $100 | Maintains | Overweight | Get Alert |
| 09/19/2023 | Buy Now | 24.21% | Evercore ISI Group | Elizabeth Anderson47% | $81 → $83 | Upgrade | In-Line → Outperform | Get Alert |
| 09/14/2023 | Buy Now | 30.2% | Cantor Fitzgerald | Sarah James51% | → $87 | Reiterates | Overweight → Overweight | Get Alert |
| 09/12/2023 | Buy Now | 19.72% | Wolfe Research | Justin Lake31% | → $80 | Upgrade | Peer Perform → Outperform | Get Alert |
| 09/01/2023 | Buy Now | 22.72% | Piper Sandler | Jessica Tassan39% | $85 → $82 | Maintains | Overweight | Get Alert |
| 08/18/2023 | Buy Now | 36.19% | RBC Capital | Ben Hendrix59% | → $91 | Reiterates | Outperform → Outperform | Get Alert |
| 08/18/2023 | Buy Now | — | Edward Jones | Ashtyn Evans1% | — | Downgrade | Buy → Hold | Get Alert |
| 08/04/2023 | Buy Now | 27.21% | Raymond James | John Ransom76% | $90 → $85 | Maintains | Outperform | Get Alert |
| 08/03/2023 | Buy Now | 46.66% | Truist Securities | David Macdonald65% | $103 → $98 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | 64.62% | Morgan Stanley | Erin Wright75% | $120 → $110 | Maintains | Overweight | Get Alert |
| 08/03/2023 | Buy Now | 36.19% | RBC Capital | Ben Hendrix59% | $102 → $91 | Maintains | Outperform | Get Alert |
| 08/03/2023 | Buy Now | 28.7% | Barclays | Steve Valiquette52% | $89 → $86 | Maintains | Overweight | Get Alert |
| 07/12/2023 | Buy Now | 33.19% | Barclays | Steve Valiquette52% | $90 → $89 | Maintains | Overweight | Get Alert |
| 07/11/2023 | Buy Now | 31.7% | Mizuho | Ann Hynes86% | $120 → $88 | Maintains | Buy | Get Alert |
| 07/07/2023 | Buy Now | 58.64% | JP Morgan | Lisa Gill56% | $114 → $106 | Maintains | Overweight | Get Alert |
| 06/20/2023 | Buy Now | 54.15% | Truist Securities | David Macdonald65% | $109 → $103 | Maintains | Buy | Get Alert |
| 05/30/2023 | Buy Now | 70.61% | JP Morgan | Lisa Gill56% | $125 → $114 | Maintains | Overweight | Get Alert |
| 05/26/2023 | Buy Now | 27.21% | Piper Sandler | Jessica Tassan39% | → $85 | Initiates | → Overweight | Get Alert |
| 05/09/2023 | Buy Now | 52.65% | RBC Capital | Ben Hendrix59% | → $102 | Reiterates | → Outperform | Get Alert |
| 05/08/2023 | Buy Now | 13.74% | Wells Fargo | Stephen Baxter54% | $95 → $76 | Maintains | Equal-Weight | Get Alert |
| 05/08/2023 | Buy Now | 43.67% | Credit Suisse | A.J. Rice70% | $125 → $96 | Maintains | Outperform | Get Alert |
| 05/08/2023 | Buy Now | 34.69% | Raymond James | John Ransom76% | $110 → $90 | Maintains | Outperform | Get Alert |
| 05/05/2023 | Buy Now | 31.7% | Goldman Sachs | Nathan Rice56% | $100 → $88 | Maintains | Buy | Get Alert |
| 05/04/2023 | Buy Now | 31.7% | Goldman Sachs | Nathan Rich42% | $100 → $88 | Maintains | Buy | Get Alert |
| 05/04/2023 | Buy Now | 34.69% | Barclays | Steve Valiquette52% | $100 → $90 | Maintains | Overweight | Get Alert |
| 05/02/2023 | Buy Now | 40.68% | UBS | Kevin Caliendo71% | $102 → $94 | Maintains | Buy | Get Alert |
| 05/02/2023 | Buy Now | 39.18% | Bernstein | Lance Wilkes57% | $107 → $93 | Maintains | Market Perform | Get Alert |
| 04/21/2023 | Buy Now | 30.2% | Cantor Fitzgerald | Sarah James51% | → $87 | Initiates | → Overweight | Get Alert |
| 04/18/2023 | Buy Now | 66.12% | TD Cowen | Charles Ryhee50% | $118 → $111 | Maintains | Outperform | Get Alert |
| 03/31/2023 | Buy Now | 55.64% | B of A Securities | Michael Cherny78% | $111 → $104 | Maintains | Buy | Get Alert |
FAQ
What is the target price for CVS Health (CVS) stock?
The latest price target for CVS Health (NYSE:CVS) was reported by Barclays on June 2, 2025. The analyst firm set a price target for $79.00 expecting CVS to rise to within 12 months (a possible 18.23% upside). 43 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CVS Health (CVS)?
The latest analyst rating for CVS Health (NYSE:CVS) was provided by Barclays, and CVS Health maintained their overweight rating.
When was the last upgrade for CVS Health (CVS)?
The last upgrade for CVS Health Corp happened on February 13, 2025 when Leerink Partners raised their price target to $75. Leerink Partners previously had a market perform for CVS Health Corp.
When was the last downgrade for CVS Health (CVS)?
The last downgrade for CVS Health Corp happened on May 7, 2024 when TD Cowen changed their price target from $99 to $59 for CVS Health Corp.
When is the next analyst rating going to be posted or updated for CVS Health (CVS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CVS Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CVS Health was filed on June 2, 2025 so you should expect the next rating to be made available sometime around June 2, 2026.
Is the Analyst Rating CVS Health (CVS) correct?
While ratings are subjective and will change, the latest CVS Health (CVS) rating was a maintained with a price target of $82.00 to $79.00. The current price CVS Health (CVS) is trading at is $66.82, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
